A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre, International Phase 3 Study to determine the Preventive Effect of Denosumab on Breast Cancer in Women carrying a BRCA1 Mutation

Project: Research

AcronymBRCA-P
StatusActive
Effective start/end date20/09/1919/09/24

Keywords

  • clinical trial
  • phase 3 study
  • breast cancer
  • treatment efficacy